X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/atossa-therapeutics-and-quantum-leap-healthcare-provide-enrollment-update-for-z-endoxifen-arm-of-ongoing-i-spy-2-clinical-trial-301865328.html
https://www.clinicaltrialsarena.com/news/atossa-pk-run-in-cohort/
https://www.globenewswire.com/news-release/2023/05/23/2674159/30326/en/Societal-CDMO-Enters-Agreement-With-Atossa-Therapeutics-to-Provide-Clinical-Trial-Services-CTS-for-Innovative-Selective-Estrogen-Receptor-Modulator.html
https://www.prnewswire.com/news-releases/atossa-therapeutics-and-quantum-leap-healthcare-announce-new-study-arm-to-evaluate-z-endoxifen-in-the-ongoing-i-spy-2-clinical-trial-301777755.html
https://www.barrons.com/articles/atossa-therapeutics-inc-to-acquire-stake-in-privately-held-dynamic-cell-therapies-as-part-of-overall-car-t-strategy-01667308958
https://www.globenewswire.com/news-release/2021/06/09/2244416/0/en/Atossa-Therapeutics-Announces-Final-Data-from-Phase-2-Endoxifen-Breast-Cancer-Study-Primary-Endpoint-Met-65-1-Reduction-in-Biomarker-Ki-67-Secondary-Endpoint-Met-Endoxifen-Safe-and.html
https://www.globenewswire.com/news-release/2021/06/07/2242805/0/en/Atossa-Therapeutics-to-Release-Final-Data-from-Phase-2-Study-of-Endoxifen-Administered-to-Breast-Cancer-Patients-Prior-to-Surgery-at-a-Webinar-at-8-am-Pacific-Time-on-June-9-2021.html
https://www.globenewswire.com/news-release/2021/04/08/2206823/0/en/Atossa-Therapeutics-Announces-Ovarian-Cancer-Patient-has-Begun-Treatment-with-Oral-Endoxifen-under-FDA-s-Expanded-Access-Pathway.html
https://www.globenewswire.com/news-release/2021/03/11/2191501/0/en/Atossa-Therapeutics-Announces-Receipt-of-FDA-Safe-to-Proceed-Letter-for-Treatment-of-an-Ovarian-Cancer-Patient-with-Oral-Endoxifen-Under-Expanded-Access-Pathway.html
https://www.globenewswire.com/news-release/2021/02/25/2182576/0/en/Atossa-Therapeutics-Announces-Final-Results-from-Phase-1-Clinical-Study-Showing-Safety-and-Tolerability-of-AT-301-Nasal-Spray-Being-Developed-for-COVID-19.html
Market Place
Share 
